| Market Cap | ₹849Cr |
| ROE | 11.36% |
| P/E Ratio(TTM) | 22.09 |
| EPS(TTM) | 32.60 |
| P/B Ratio | 3.32 |
| Dividend Yield | 0.10% |
| Industry P/E | 34.85 |
| Book Value | 217.13 |
| Debt to Equity | 0.09 |
| Face Value | 10 |
| Parent Organisation | Remus Pharmaceuticals |
| Managing Director | Mr. Arpit Shah |
| NSE Symbol | REMUS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 75.76 | ||
| Anthem Biosciences | NA (0.00%) | 88.36 | ||
| Onesource Specialty Pharma | NA (0.00%) | -1687.77 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 24.74 |